Intracranial haemorrhage 4 days after receiving thrombolytic therapy in a young woman with myocardial infarction

Ali, Sameera Mohamed; Rajani, Ali Raza; Baslaib, Fahad Omar
May 2013
BMJ Case Reports;May2013, p1
Academic Journal
No abstract available.


Related Articles

  • Tenecteplase.  // Reactions Weekly;7/13/2013, Issue 1461, p35 

    An abstract of the article "Intracranial haemorrhage 4 days after receiving thrombolytic therapy in a young woman with myocardial infarction," by S. M. Ali and colleagues is presented.

  • Alteplase.  // Reactions Weekly;3/6/2010, Issue 1291, p5 

    The article describes the case of a man who developed embolic acute myocardial infarction after receiving thrombolytic therapy with alteplase for presumed stroke.

  • Thrombolysis for Evolving Myocardial Infarction.  // Annals of Internal Medicine;Sep85, Vol. 103 Issue 3, p463 

    Examines the application of thrombolytic therapy for evolving myocardial infarction. Role of coronary thrombosis in the pathogenesis of acute myocardial infarction; Objectives of thrombolytic therapy; Risks of thrombolytic therapy.

  • Thrombolysis in patients with a brain tumour. Rubinshtein, R.; Jaffe, R.; Flugelman, M. Y.; Karkabi, B.; Lewis, B. S. // Heart;Dec2004, Vol. 90 Issue 12, p1476 

    The article reports about thrombolysis in patients with a brain tumor. Many potentially eligible patients (30-50%) with acute elevation myocardial infarction do not currently receive thrombolytic treatment, partly because of the presence of a contraindication. Intracranial haemorrhage is a...

  • Bleeding during Thrombolytic Therapy for Acute Myocardial Infarction: Mechanisms and Management. Sane, David; Califf, Robert; Topol, Eric; Stump, David; Mark, Daniel; Greenberg, Charles // Annals of Internal Medicine;12/15/89, Vol. 111 Issue 12, p1010 

    Presents a study on the management of patients who are receiving thrombolytic therapy for acute myocardial infarction. Adverse effect of thrombolytic therapy; Conditions associated with the risk of hemorrhage; Pharmaceutical agents for lysing pathologic thrombi; Principles of transfusion therapy.

  • Acute Myocardial Infarction in a Patient with Behçet's Disease. Beyranvand, Mohammad-Reza; Namazi, Mohammad-Hassan; Mohsenzadeh, Yusef; Piranfar, Mohammad Assadpour // Archives of Iranian Medicine (AIM);May2009, Vol. 12 Issue 3, p313 

    A 37-year-old man, a known case of Behcets disease with its vascular complications such as abdominal and thoracic artery aneurysms, was admitted with the diagnosis of acute anterior myocardial infarction and received thrombolytic therapy. Coronary angiography and percutaneous coronary...

  • Acute MI: Older patients less likely to receive thrombolytic therapy.  // Geriatrics;Aug97, Vol. 52 Issue 8, p22 

    States that the likelihood of eligible myocardial infarction (MI) patients receiving thrombolytic therapy decreases with increasing age. Explanation of Doctor Harlan M. Krumholz, assistant professor of medicine, Yale University about thrombolytic therapy.

  • Drugs that dissolve clots. Braun, Anne E.; Moore, Kathleen A. // RN;Jun91, Vol. 54 Issue 6, p52 

    Deals with the use of thrombolytic therapy for the treatment of myocardial infarction. Details on how thrombolytic agents dissolve clots; Assessment of patient after thrombolytic therapy; Guidelines on the administration and protocols for care; Indications that the blood clots were dissolved. ...

  • Streptokinase.  // Reactions Weekly;9/19/2009, Issue 1270, p34 

    The article describes the case of a 38-year-old woman who received thrombolytic therapy with intravenous streptokinase following an acute myocardial infarction. The patient started receiving aspirin, β-blockers, nitrates and angiotensin-converting enzyme (ACE) inhibitors. After receiving...

  • Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. French, John K.; Williams, Barbara F. // BMJ: British Medical Journal (International Edition);6/29/96, Vol. 312 Issue 7047, p1637 

    Determines the proportion of patients presenting with acute myocardial infarction who are eligible for thrombolytic therapy in Auckland, New Zealand. Eligibility for thrombolytic therapy; Mortality rates of myocardial infarction patients; Cautions with thrombolytic therapy. INSET: Key messages..


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics